Lionco Pharmaceutical Group Co.,Ltd.
SSE:603669.SS
5.23 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -130.764 | -151.496 | -195.748 | 65.904 | 160.073 | 201.592 | 182.704 | 161.005 | 153.925 | 149.694 | 149.858 | 114.799 | 95.173 | 55.754 |
| Depreciation & Amortization
| 36.345 | 49.448 | 45.324 | 43.096 | 37.564 | 35.545 | 29.712 | 29.529 | 27.318 | 24.209 | 24.399 | 11.7 | 15.98 | 0 |
| Deferred Income Tax
| 0 | 0 | 6.658 | -2.513 | -0.985 | -0.722 | 0.607 | -0.431 | 5.295 | -1.369 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.5 | 0 |
| Change In Working Capital
| -82.242 | 27.007 | 50.132 | 12.31 | -96.291 | -10.441 | -21.889 | 5.375 | 14.011 | -68.666 | 1.566 | 26.277 | 9.127 | 0 |
| Accounts Receivables
| -201.432 | 4.807 | 46.639 | 42.646 | 62.655 | -58.176 | 28.002 | -144.684 | -4.138 | -60.308 | 34.014 | 0 | 0 | 0 |
| Inventory
| 26.262 | -17.339 | 1.548 | 15.826 | 19.942 | -21.774 | 21.319 | -10.679 | 5.741 | -7.776 | -4.335 | -6.67 | -4.897 | 0 |
| Accounts Payables
| 0 | 39.847 | -4.713 | -43.649 | -177.903 | 70.231 | -71.818 | 161.169 | 7.113 | 0.788 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 92.927 | -0.308 | 6.658 | -2.513 | -0.985 | -0.722 | -43.208 | 16.054 | 8.27 | -60.89 | 5.902 | 32.947 | 14.023 | 0 |
| Other Non Cash Items
| 65.772 | 37.165 | 33.935 | 7.193 | 25.468 | 8.908 | -4.653 | -6.904 | -12.983 | -6.36 | 5.676 | 7.998 | 22.33 | -55.754 |
| Operating Cash Flow
| -110.889 | -37.875 | -66.357 | 128.503 | 126.814 | 235.605 | 185.874 | 189.005 | 182.27 | 98.878 | 181.5 | 160.773 | 142.611 | 0 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -8.848 | -23.132 | -42.838 | -54.816 | -61.95 | -10.867 | -173.696 | -86.568 | -88.935 | -70.104 | -116.698 | -103.966 | -109.637 | -24.737 |
| Acquisitions Net
| 0 | 0.18 | 2.62 | 0.006 | 0.073 | 0.2 | 0 | 0.038 | 0.076 | 0 | 0 | -2.554 | 0 | -32.512 |
| Purchases Of Investments
| 0 | -30 | -30 | -2 | -2 | -1,376 | -100 | 0 | -903.48 | -615 | 0 | 0 | 0 | -0.12 |
| Sales Maturities Of Investments
| 8.099 | 15.611 | 15.938 | 18.721 | 24.725 | 20.846 | 23.531 | 21.022 | 32.894 | 0.032 | 0.836 | 0.66 | 0.04 | 0.005 |
| Other Investing Activites
| 366.535 | -14.557 | 185.824 | -394.757 | 167 | 1,354 | 175 | 0.475 | 90.247 | -590.661 | 25.677 | -9.27 | 1.874 | 8.075 |
| Investing Cash Flow
| 365.786 | -51.897 | 131.544 | -432.847 | 127.847 | -11.821 | -75.165 | -65.071 | 34.206 | -660.732 | -90.185 | -115.13 | -107.723 | -49.289 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| -322.179 | -87.911 | -339.895 | -120.065 | 932.322 | -145 | 395 | 0 | -50 | 0 | 0 | 0 | 0 | -8 |
| Common Stock Issued
| 0 | 0 | 56.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -52.106 | -56.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -5.73 | -8.083 | -71.761 | -142.688 | -101.92 | -265.72 | -106.02 | -31.2 | -104.527 | -111.956 | -126.943 | 0 | 0 | -0.029 |
| Other Financing Activities
| 5.83 | -10.889 | -5.428 | 0.383 | -18.482 | -3.614 | -4.131 | -0.031 | 0.423 | 753.243 | -3.193 | 0 | -32.446 | -12.608 |
| Financing Cash Flow
| -322.078 | -158.99 | -473.346 | -278.893 | 811.92 | -427.926 | 284.85 | -31.231 | -154.631 | 645.993 | -129.943 | 0 | -32.446 | -20.636 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Net Change In Cash
| -67.181 | -248.761 | -408.16 | -583.238 | 1,066.581 | -204.142 | 395.558 | 92.703 | 61.845 | 84.139 | -38.628 | 45.643 | 2.442 | 28.301 |
| Cash At End Of Period
| 247.269 | 314.451 | 563.212 | 971.372 | 1,554.609 | 488.028 | 692.17 | 296.612 | 203.909 | 142.063 | 57.924 | 96.553 | 50.91 | 48.468 |